Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Interim Management Statement

6 May 2010 07:00

Thursday 6 May 2010 SOPHEON PLC ("Sopheon" or the "Company") INTERIM MANAGEMENT STATEMENT Sopheon plc, the international provider of software and services that improvethe financial return from innovation and product development investments,announces its first interim management statement for the period since 1 January2010 to the date of this announcement, in line with the requirements of the EUTransparency Directive.Sopheon has continued to add business since the end of last year, building onthe improved performance of the fourth quarter. Since the start of 2010, wehave closed 12 new and extension license orders. Business from existingcustomers continues to hold up well. Revenue visibility for the full year fromcontracted business and recurring revenue streams now stands at £5.6 million,compared to £4.8 million on 24 March, the time of our last update. Totalreported revenue for 2009 was £8.3 million. Operating costs before R&Dcapitalization were approximately £0.5 million lower in the first quarter of2010 compared to the first quarter of 2009, reflecting the fact that costadjustments taken last year took effect in the second quarter. Gross cashresources at the end of the first quarter of 2010 stood at £1.7 million.The market is responding favourably to the new product enhancements that weintroduced in 2009. Since the start of the year we have continued to innovateand deliver new solutions. Most recently, we announced the launch of www.isustain.com in partnership with Cytec Industries and the Beyond BenignFoundation. The site enables users to assess the sustainability of productformulations through an iSUSTAIN Green Chemistry Index rating, which can beindependently certified if required. Users that wish to migrate beyond a basiclevel of interaction with the site will be required to enter into paid-forsubscriptions.Our sales pipeline continues to show encouraging activity, and suggests aresurgent appetite amongst large corporations to make positive purchasedecisions where they perceive real business benefits. Predicting the timing andvalue of individual sales remains challenging, which can inevitably impact onthe business performance. However, major analyst organisations like Forrester,Gartner and IDC continue to see growing traction and opportunity in our chosenmarket. In December 2009, Forrester noted increasing interest and investment inproject and portfolio management tools for product development (PPM) and in thesame month Gartner noted that software that supports product strategy andplanning is gaining attention as a segment of the product lifecycle management(PLM) software market. Forrester also identified Sopheon as one of the clearmarket share leaders in the PPM space.

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Sopheon plc Tel : + 44 (0) 1483 685 735 Justine James / Hansard Communications Tel : + 44 (0) 20 7245 1100 Kirsty Corcoran Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 Catherine Leftley / Seymour Pierce Corporate Tel: +44 (0) 20 7107 8000 Jonathan Wright Finance About SopheonSopheon is an international provider of software and services thathelp organisations improve the business impact of product innovation. Sopheon'ssolutions automate and govern the innovation process, enabling companies toincrease revenue and profits from new products. Sopheon's solutions are used byindustry leaders throughout the world, including BASF, Cadbury, Corning,Electrolux, Honeywell, Motorola and SABMiller. Sopheon is listed on the AIMMarket of the London Stock Exchange and on the Euronext in the Netherlands. Formore information, please visit www.sopheon.com.

vendor
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.